"Het is meer dan alleen een leefstijlprobleem."
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia, obstructive sleep apnea or cardiovascular disease)
Where ever you are finding yourself, I want you to remember that obesity is a disease, one you deserve comprehensive treatment for
Tirzepatides dual agonist mechanism may accelerate progress, with some people reporting accelerated weight drops during the second month especially at doses above 10 mg (Journal of Clinical Medicine Research)
What if my luggage is delayed and I miss a dose of semaglutide
Peptide drugs like semaglutide are notoriously difficult to deliver orally